HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Combretastatin A-1 phosphate potentiates the antitumour activity of cisplatin in a murine adenocarcinoma model.

AbstractBACKGROUND:
The tubulin depolymerizing drug Combretastatin A-1 phosphate (CA1P), a water-soluble derivative of combretastatin A-1, has been recently shown to have a better efficacy in experimental models than the clinically active, close structural analogue, combretastatin A-4 phosphate (CA4P). Previous studies with CA4P in combination with standard anti-cancer agents have demonstrated improved efficacy relative to the standard agents.
MATERIALS AND METHODS:
In this study the synergistic effects of administering CA1P in combination with cisplatin (CPL) in a well-differentiated transplantable murine colon model (MAC 29) was evaluated.
RESULTS:
CA1P at 100 mgkg-1 significantly potentiated the anti-tumour effects of CPL. The effect with CPL was similar to that seen for CA1P at its maximum tolerated dose (MTD) alone.
CONCLUSION:
These data demonstrate that the combination of CA1P and CPL has significant preclinical antitumour activity against a transplantable murine adenocarcinoma model that is related to the antivascular effects of CA1P.
AuthorsS D Shnyder, P A Cooper, G R Pettit, J W Lippert 3rd, M C Bibby
JournalAnticancer research (Anticancer Res) 2003 Mar-Apr Vol. 23 Issue 2B Pg. 1619-23 ISSN: 0250-7005 [Print] Greece
PMID12820431 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Angiogenesis Inhibitors
  • Antineoplastic Agents
  • Stilbenes
  • combretastatin A-1
  • Cisplatin
Topics
  • Adenocarcinoma, Mucinous (blood supply, drug therapy, pathology)
  • Angiogenesis Inhibitors (administration & dosage, pharmacology)
  • Animals
  • Antineoplastic Agents (therapeutic use)
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Cisplatin (administration & dosage, pharmacology, therapeutic use)
  • Colonic Neoplasms (pathology)
  • Drug Screening Assays, Antitumor
  • Drug Synergism
  • Female
  • Mice
  • Mice, Inbred Strains
  • Neoplasm Transplantation
  • Stilbenes (administration & dosage, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: